会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明专利
    • Carcinostatic intensifier
    • 致癌细胞
    • JPS6160612A
    • 1986-03-28
    • JP18238484
    • 1984-08-31
    • Eisai Co Ltd
    • SETO TOSHIOSUZUKI YOSHIKAZU
    • A61K31/20A61K31/19A61P35/00C07C57/03
    • A61K31/19
    • PURPOSE: A safe carcinostatic intensifier that contains, as an active ingredient, 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or its salt, thus intensifying carcinostatic effect by synergism in combination with another carcinostatic agent.
      CONSTITUTION: 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenoic acid of the formula and its salt are used as a carcinostatic intensifier. The compound of the formula is known as an anticancer and remedy for dermatopathy, but the inventors have found that it strongly intensifies its carcinostatic effect, when combined with another known carcinostatic agent. Especially, this effect is markedly developed in combination with 5-Fu, MMC, REP, Further, the compound of the formula is structurally completely novel and shows high safety, therefore its clinical value is high.
      COPYRIGHT: (C)1986,JPO&Japio
    • 目的:一种安全的致癌增强剂,含有作为活性成分的3,7,11,15-四甲基-2,4,6,10,14-十六碳五烯酸或其盐,从而通过与另一种组合的协同作用增强制癌的作用 制癌剂。 构成:将下式的3,7,11,15-四甲基-2,4,6,10,14-十六碳五烯酸及其盐用作制癌增强剂。 该化合物被称为皮肤病的抗癌和补救剂,但是发明人已经发现,当与另一种已知的制癌剂组合时,其强烈地增强其制癌作用。 特别是与5-Fu,MMC,REP组合显着发挥作用。此外,式中化合物结构完全新颖,安全性高,临床价值高。